Is Repatha an Injection or a Pill?
Repatha (evolocumab) is an injection, not a pill. It's administered as a subcutaneous shot, typically every 2 or 4 weeks, using a prefilled syringe, SureClick autoinjector, or Pushtronex system.[1]
How Do You Take Repatha?
Patients self-inject into the abdomen, thigh, or upper arm. Starting dose is 140 mg every 2 weeks or 420 mg monthly. No oral version exists; it's a PCSK9 inhibitor monoclonal antibody that must be injected for absorption.[1][2]
Why Injection Instead of a Pill?
Monoclonal antibodies like Repatha degrade in the stomach, so injection bypasses digestion for direct bloodstream delivery. Oral PCSK9 inhibitors are in trials but not approved.[2]
Repatha vs. Other Cholesterol Drugs
| Drug | Form | How It Lowers Cholesterol |
|------|------|---------------------------|
| Repatha | Injection | Blocks PCSK9 to boost LDL receptor recycling |
| Crestor (rosuvastatin) | Pill | Statin; inhibits cholesterol synthesis |
| Nexletol (bempedoic acid) | Pill | Blocks ATP citrate lyase in liver |
| Leqvio (inclisiran) | Injection (twice yearly) | siRNA that inhibits PCSK9 production |
Repatha pairs with statins for high-risk patients; pills like statins are daily and cheaper but less potent for some.[1][3]
Common Patient Questions on Repatha Injections
Injection site reactions (redness, pain) affect 5-10% of users. No refrigeration needed after first use; store at room temp up to 30 days. Missed dose? Inject ASAP, resume schedule.[1]
Cost and Access for Repatha
List price ~$5,800/month, but copay cards drop it to $5-25 for eligible patients. Covered by most insurance for familial hypercholesterolemia or statin-intolerant cases.[3]
Patents and Generic/Biosimilar Outlook
Repatha patents expire 2034-2036 in the US; Amgen holds exclusivities until 2025. No biosimilars approved yet, but challenges from Regeneron and others ongoing.4
[1]: Repatha.com (official prescribing info)
[2]: FDA.gov (Repatha approval label)
[3]: GoodRx.com (pricing and comparisons)